annual CFO:
$118.67M+$109.87M(+1248.55%)Summary
- As of today (May 29, 2025), ADMA annual cash flow from operations is $118.67 million, with the most recent change of +$109.87 million (+1248.55%) on December 31, 2024.
- During the last 3 years, ADMA annual CFO has risen by +$231.04 million (+205.61%).
- ADMA annual CFO is now at all-time high.
Performance
ADMA Cash from operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFO:
-$19.68M-$69.89M(-139.18%)Summary
- As of today (May 29, 2025), ADMA quarterly cash flow from operations is -$19.68 million, with the most recent change of -$69.89 million (-139.18%) on March 31, 2025.
- Over the past year, ADMA quarterly CFO has dropped by -$17.46 million (-787.06%).
- ADMA quarterly CFO is now -139.18% below its all-time high of $50.22 million, reached on December 31, 2024.
Performance
ADMA quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
$101.22M-$17.46M(-14.71%)Summary
- As of today (May 29, 2025), ADMA TTM cash flow from operations is $101.22 million, with the most recent change of -$17.46 million (-14.71%) on March 31, 2025.
- Over the past year, ADMA TTM CFO has increased by +$79.91 million (+375.08%).
- ADMA TTM CFO is now -14.71% below its all-time high of $118.67 million, reached on December 31, 2024.
Performance
ADMA TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
ADMA Cash from operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +1248.5% | -787.1% | +375.1% |
| 3 y3 years | +205.6% | +24.4% | +196.3% |
| 5 y5 years | +255.8% | +20.2% | +216.9% |
ADMA Cash from operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +205.6% | -139.2% | +24.4% | -14.7% | +196.3% |
| 5 y | 5-year | at high | +205.6% | -139.2% | +41.2% | -14.7% | +183.3% |
| alltime | all time | at high | +205.6% | -139.2% | +41.2% | -14.7% | +183.3% |
ADMA Cash from operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$19.68M(-139.2%) | $101.22M(-14.7%) |
| Dec 2024 | $118.67M(+1248.5%) | $50.22M(+100.6%) | $118.67M(+37.9%) |
| Sep 2024 | - | $25.03M(-45.2%) | $86.05M(+17.9%) |
| Jun 2024 | - | $45.65M(-2158.0%) | $73.01M(+242.7%) |
| Mar 2024 | - | -$2.22M(-112.6%) | $21.30M(+142.1%) |
| Dec 2023 | $8.80M(-114.8%) | $17.60M(+46.8%) | $8.80M(-154.4%) |
| Sep 2023 | - | $11.98M(-297.8%) | -$16.18M(-61.0%) |
| Jun 2023 | - | -$6.06M(-58.8%) | -$41.45M(-14.0%) |
| Mar 2023 | - | -$14.72M(+99.5%) | -$48.22M(-19.0%) |
| Dec 2022 | -$59.51M(-47.0%) | -$7.38M(-44.5%) | -$59.51M(-30.5%) |
| Sep 2022 | - | -$13.28M(+3.5%) | -$85.59M(-0.1%) |
| Jun 2022 | - | -$12.83M(-50.7%) | -$85.72M(-18.5%) |
| Mar 2022 | - | -$26.01M(-22.3%) | -$105.15M(-6.4%) |
| Dec 2021 | -$112.37M(+10.2%) | -$33.47M(+149.5%) | -$112.37M(+1.1%) |
| Sep 2021 | - | -$13.41M(-58.4%) | -$111.12M(-8.6%) |
| Jun 2021 | - | -$32.26M(-2.9%) | -$121.56M(+9.9%) |
| Mar 2021 | - | -$33.23M(+3.1%) | -$110.59M(+8.4%) |
| Dec 2020 | -$102.00M(+33.9%) | -$32.22M(+35.1%) | -$102.00M(+14.1%) |
| Sep 2020 | - | -$23.85M(+12.1%) | -$89.44M(+0.2%) |
| Jun 2020 | - | -$21.28M(-13.6%) | -$89.21M(+3.1%) |
| Mar 2020 | - | -$24.65M(+25.4%) | -$86.55M(+13.6%) |
| Dec 2019 | -$76.19M(+21.6%) | -$19.65M(-16.8%) | -$76.19M(+1.1%) |
| Sep 2019 | - | -$23.63M(+26.9%) | -$75.33M(+17.3%) |
| Jun 2019 | - | -$18.62M(+30.4%) | -$64.25M(+6.1%) |
| Mar 2019 | - | -$14.29M(-24.0%) | -$60.53M(-3.4%) |
| Dec 2018 | -$62.68M(+68.2%) | -$18.79M(+49.8%) | -$62.68M(+9.5%) |
| Sep 2018 | - | -$12.54M(-15.9%) | -$57.24M(+5.2%) |
| Jun 2018 | - | -$14.91M(-9.3%) | -$54.44M(+12.7%) |
| Mar 2018 | - | -$16.43M(+23.0%) | -$48.31M(+29.6%) |
| Dec 2017 | -$37.27M | -$13.36M(+37.2%) | -$37.27M(+35.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2017 | - | -$9.74M(+11.0%) | -$27.53M(+22.5%) |
| Jun 2017 | - | -$8.78M(+62.6%) | -$22.47M(+21.5%) |
| Mar 2017 | - | -$5.40M(+49.4%) | -$18.50M(+1.3%) |
| Dec 2016 | -$18.27M(+18.5%) | -$3.61M(-22.8%) | -$18.27M(-2.5%) |
| Sep 2016 | - | -$4.68M(-2.5%) | -$18.73M(+12.0%) |
| Jun 2016 | - | -$4.80M(-7.0%) | -$16.72M(+2.2%) |
| Mar 2016 | - | -$5.17M(+26.7%) | -$16.37M(+6.1%) |
| Dec 2015 | -$15.42M(+4.9%) | -$4.08M(+52.6%) | -$15.42M(+8.3%) |
| Sep 2015 | - | -$2.67M(-39.9%) | -$14.24M(+1.5%) |
| Jun 2015 | - | -$4.45M(+5.3%) | -$14.04M(+1.1%) |
| Mar 2015 | - | -$4.22M(+45.4%) | -$13.89M(-5.6%) |
| Dec 2014 | -$14.70M(+35.1%) | -$2.90M(+17.7%) | -$14.70M(-0.4%) |
| Sep 2014 | - | -$2.47M(-42.6%) | -$14.76M(+1.7%) |
| Jun 2014 | - | -$4.30M(-14.8%) | -$14.52M(+13.0%) |
| Mar 2014 | - | -$5.04M(+70.3%) | -$12.85M(+18.1%) |
| Dec 2013 | -$10.89M(+57.7%) | -$2.96M(+33.0%) | -$10.89M(+11.8%) |
| Sep 2013 | - | -$2.23M(-15.3%) | -$9.73M(+1.3%) |
| Jun 2013 | - | -$2.63M(-14.6%) | -$9.61M(+20.4%) |
| Mar 2013 | - | -$3.07M(+70.2%) | -$7.98M(+15.6%) |
| Dec 2012 | -$6.90M(>+9900.0%) | -$1.81M(-14.0%) | -$6.90M(+35.1%) |
| Sep 2012 | - | -$2.10M(+110.8%) | -$5.11M(+69.6%) |
| Jun 2012 | - | -$996.90K(-50.1%) | -$3.01M(+48.9%) |
| Mar 2012 | - | -$2.00M(>+9900.0%) | -$2.02M(+6739.2%) |
| Dec 2011 | - | -$12.80K(+146.2%) | -$29.60K(+14.7%) |
| Sep 2011 | - | -$5200.00(-32.5%) | -$25.80K(-11.0%) |
| Jun 2011 | -$29.00K(+47.2%) | -$7700.00(+97.4%) | -$29.00K(+36.2%) |
| Mar 2011 | - | -$3900.00(-56.7%) | -$21.30K(+22.4%) |
| Dec 2010 | - | -$9000.00(+7.1%) | -$17.40K(+107.1%) |
| Sep 2010 | - | -$8400.00 | -$8400.00 |
| Jun 2010 | -$19.70K | - | - |
FAQ
- What is ADMA Biologics annual cash flow from operations?
- What is the all time high annual CFO for ADMA Biologics?
- What is ADMA Biologics annual CFO year-on-year change?
- What is ADMA Biologics quarterly cash flow from operations?
- What is the all time high quarterly CFO for ADMA Biologics?
- What is ADMA Biologics quarterly CFO year-on-year change?
- What is ADMA Biologics TTM cash flow from operations?
- What is the all time high TTM CFO for ADMA Biologics?
- What is ADMA Biologics TTM CFO year-on-year change?
What is ADMA Biologics annual cash flow from operations?
The current annual CFO of ADMA is $118.67M
What is the all time high annual CFO for ADMA Biologics?
ADMA Biologics all-time high annual cash flow from operations is $118.67M
What is ADMA Biologics annual CFO year-on-year change?
Over the past year, ADMA annual cash flow from operations has changed by +$109.87M (+1248.55%)
What is ADMA Biologics quarterly cash flow from operations?
The current quarterly CFO of ADMA is -$19.68M
What is the all time high quarterly CFO for ADMA Biologics?
ADMA Biologics all-time high quarterly cash flow from operations is $50.22M
What is ADMA Biologics quarterly CFO year-on-year change?
Over the past year, ADMA quarterly cash flow from operations has changed by -$17.46M (-787.06%)
What is ADMA Biologics TTM cash flow from operations?
The current TTM CFO of ADMA is $101.22M
What is the all time high TTM CFO for ADMA Biologics?
ADMA Biologics all-time high TTM cash flow from operations is $118.67M
What is ADMA Biologics TTM CFO year-on-year change?
Over the past year, ADMA TTM cash flow from operations has changed by +$79.91M (+375.08%)